Form 10-Q · Quarterly report
Trane Technologies 10-Q, filed Oct 29, 2026
- Filed
- CIK
- 0001466258
- Accession no.
- 0001628280-26-068122
Summary
Trane Technologies reported third-quarter 2026 net revenues of $6.76 billion, up 17.7% from a year earlier, and net earnings of $1.05 billion, while continuing a string of data-center cooling acquisitions including Stellar Energy Americas and full ownership of LiquidStack.
Key points
- Net revenues rose 17.7% to $6.76 billion from $5.74 billion in the same quarter of 2025, with organic revenue up 16.2%, volume up 15.7% and acquisitions contributing 1.6%.
- Net earnings were $1.05 billion versus $850.8 million a year earlier, and gross profit margin fell 160 basis points to 35.3% on inflation and investments, partly offset by productivity and price realization.
- Trane acquired Stellar Energy Americas, a turnkey data center cooling provider, on February 17, 2026, and bought the remaining interest in liquid-cooling provider LiquidStack during the nine months ended September 30, 2026.
- Trane also acquired a 49% equity-method stake in building automation provider Kieback&Peter and announced in October 2026 its intent to acquire heat-transfer manufacturer Cancoil Thermal Corporation, expected to close no later than the first quarter of 2027.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2 – Management's Discussion Overview Organizational Trane Technologies plc is a global climate innovator. We bring sustainable and efficient solutions to buildings, homes and transportation through our strategic brands, Trane® and Thermo King®, and our environmentally responsible portfolio of products, services and connected intelligent controls. 2030 Sustainability Commitments Our commitment to sustainability extends to the environmental and social impacts of our people, operations, products and services. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.